New Test Helps Evaluate Breast Cancer Patients for Herceptin Use (HealthDay)

Admin

Administrator
Staff member
HealthDay - TUESDAY, June 14 (HealthDay News) -- A genetic test to help doctors evaluate whether women with breast cancer are candidates for treatment with the drug Herceptin (trastuzumab) has been approved by the U.S. Food and Drug Administration.

More...
 
Top